These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4323571)

  • 1. [Isolation and certain properties of a protective antigen from B. pertussis].
    Lapaeva IA; Zakharova MS; Pereverzev NA
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Nov; 47(11):27-30. PubMed ID: 4323571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenic and antigenic properties of soluble pertussis antigens].
    Moskalenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Sep; 46(9):42-6. PubMed ID: 4311503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protective antigens of the pertussis microbe isolated by various methods].
    Lapaeva IA; Zakharova MS; Pavlova IB
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Aug; 43(8):72-7. PubMed ID: 4307574
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extraction of a highly purified agglutinogen of B. pertussis].
    Denisova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):97-101. PubMed ID: 4308063
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of major 1, 2, and 3 agglutinant antigens of Bordetella pertussis strains isolated from Brazilian children with whooping-cough treated at the Emilio Ribas Hospital of São Paulo, Brazil].
    Timo iaria S
    Rev Saude Publica; 1977 Sep; 11(3):410-5. PubMed ID: 203021
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of protective antigen from Bordetella pertussis.
    Sato Y; Nagase KI
    Biochem Biophys Res Commun; 1967 Apr; 27(2):195-201. PubMed ID: 4291987
    [No Abstract]   [Full Text] [Related]  

  • 7. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic studies of pertussis. Development of precipitins.
    Aftandelians R; Connor JD
    J Pediatr; 1973 Aug; 83(2):206-14. PubMed ID: 4352206
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic study of surface antigen extracted with sodium deoxycholate from the whooping cough microbe].
    Demina AA; Larina LI; Gracheva AM; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):36-9. PubMed ID: 4302272
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical and biological properties of the purified O antigen of Bordetella pertussis.
    Nakase Y; Tateishi M; Sekiya K; Kasuga T
    Jpn J Microbiol; 1970 Jan; 14(1):1-8. PubMed ID: 4313572
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Protective activity of whooping-cough convalescent serum and serum-IgA level in mice infected with Bordetella pertussis.
    Pittman M
    Lancet; 1976 Jul; 2(7977):156. PubMed ID: 59233
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific IgE-antibodies to Bordetella pertussis antigens during whooping cough.
    Wirsing von Koenig CH; Finger H
    Lancet; 1989 Apr; 1(8640):728. PubMed ID: 2564540
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extraction of the soluble antigens of B. pertussis during cultivation in a fluid nutrient medium].
    Igonina IuA; Trofimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):133-4. PubMed ID: 4308061
    [No Abstract]   [Full Text] [Related]  

  • 18. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On soluble fractions of the agent of whooping cough].
    Moskalenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jun; 45(6):63-7. PubMed ID: 4305931
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.